J9359 Medicaid reimbursement rate by state (2026)
Injection, loncastuximab tesirine-lpyl, 0.075 mg. Medicaid pays a median of $221.49 for J9359 across 35 states, from $176.49 in New Jersey to $228.61 in Indiana.
- States publishing
- 35
- National median
- $221.49units vary by state
- Lowest
- $176.49New Jersey
- Highest
- $228.61Indiana
What does Medicaid pay for J9359?
35 state Medicaid programs publish a fee-for-service rate for J9359. The national median is $221.49 (units differ between states). Indiana pays the most, $228.61 per unit, and New Jersey the least, $176.49, a 1.3x spread.
J9359 rate by state: highest, middle and lowest
One like-for-like fee-for-service rate per state, ranked. The workspace lists all 35 states with every variant, modifier and effective date.
How to read this table
- Order. States are listed from the highest published rate to the lowest. No single unit is shared by 8 or more states for J9359, so the order is by published amount and is not a like-for-like rank.
- Medicaid rate. The most the state's fee-for-service program pays for one unit, as published. 10 of the 35 states list more than one rate for J9359, by modifier, provider type or setting; the table shows the one that matches the provider level and setting used across states, without add-ons.
- Unit. Of the 35 states, 1 publish J9359 per unit and 1 per 0075 mg, and 33 schedules print no unit at all (a flat amount per service).
- Per hour. J9359 is not billed in time units in these states, so no hourly figure is shown.
- Managed-care plans. The rule the state sets for its plans on this rate. What each rule means is explained below.
- % of Medicare. No Medicare physician fee schedule amount is on file for J9359, so there is no percentage.
- Source and date. Each Source link opens the state's own document; “since” is the date the rate took effect.
Why J9359 rates differ between states
Published rates for J9359 run from $176.49 in New Jersey to $228.61 in Indiana. The two publish it in different units (unit versus no unit printed), so part of that gap is the unit rather than the price. Half the states pay more than the median of $221.49 and half pay less. The usual reasons for a spread like this in pharmacy rates:
- States differ in whether they pay a fixed fee, a percentage of a benchmark or invoice cost.
- Drugs given in a practice or clinic are commonly priced from a benchmark such as average sales price or wholesale acquisition cost, which moves every quarter.
- For children, many vaccines are supplied through the federal Vaccines for Children program, so the Medicaid payment can be for administration only.
Timing matters too. 29 states set the current rate for J9359 in 2026 or later, while 2 states still pay a rate that took effect in 2022 or earlier. A state that has not updated its rate in years will drift down the ranking as others raise theirs.
What managed-care plans pay for J9359
Most Medicaid members are in managed-care plans, and plans don't publish their provider fee schedules. For J9359, the public signal is the rule each state sets for its plans, recorded on each rate above.
In 7 states, the published rate binds plans: a floor, a pass-through or a state-set rate. In 15 states, plans negotiate and the published rate is a benchmark or out-of-network default. The rule for the remaining 13 states is not classified yet.
- Plans negotiate; the published rate applies out of network (15 states). In-network rates can be above or below the published rate. The published rate is the benchmark both sides know, and the fallback if no contract is signed.
- Plans must pay at least the published rate (6 states). The published rate is your floor. Negotiate up from it, and if a plan pays less, the contract provision is the basis for a payment dispute.
- The state sets the plan rate (1 state). There is little to negotiate on price. Contracting is about network participation, authorization and billing terms.
Plan-negotiated rates are never estimated here. To see the rule and its citation for a particular state, open that state's managed-care page, for example Indiana managed care.
Units and billing for J9359
J9359 is a HCPCS Level II drug code in the pharmacy line, billed mostly by practices and clinics that administer vaccines and drugs. J codes cover drugs that are not self-administered. One unit is the dose stated in the code, so a claim for a larger dose bills several units.
Drug codes are billed in units of the dose stated in the code, so a larger dose bills more units. Many states require the National Drug Code (NDC) on the claim alongside the billing code.
Before billing, confirm the rate, unit and any modifier with the state's current schedule or the plan: the amounts here are as published, not a guarantee of payment.
Frequently asked questions
What does Medicaid pay for J9359?
It depends on the state. Of the 35 states with a published fee-for-service rate, the median is $221.49. Indiana pays the most ($228.61 per unit) and New Jersey the least ($176.49).
Which state pays the highest Medicaid rate for J9359?
Indiana, at $228.61 per unit, effective 2026-04-01.
Which state pays the lowest Medicaid rate for J9359?
New Jersey, at $176.49, effective 2025-01-01. It publishes the code in a different unit from Indiana, so compare per unit with care.
What unit is J9359 billed in?
Of the 35 states, 1 publish J9359 per unit and 1 per 0075 mg, and 33 schedules print no unit at all (a flat amount per service).
Do managed-care plans pay the same rate for J9359?
Not necessarily. In 7 states, the published rate binds plans: a floor, a pass-through or a state-set rate. In 15 states, plans negotiate and the published rate is a benchmark or out-of-network default. The rule for the remaining 13 states is not classified yet. Each rule is cited to the plan contract, statute or notice in the workspace.